$14.20 -0.19 (-1.32%)
11/27/2009 1:00 PM

Somanetics Corp (SMTS)

CAPS Rating: 5 out of 5

Develops, manufactures and markets the INVOS Cerebral Oximeter, the only non-invasive patient monitoring system commercially available in the United States that continuously measures changes in the blood oxygen level in the adult brain.

Results 1 - 20 of 31 1 2 Next »

Recs

0
Member Avatar bluecollarbroker (99.05) Submitted: 11/15/2009 11:42:15 PM : Outperform Start Price: $14.15 SMTS Score: +1.09

value

Recs

0
Member Avatar pchristoph (61.06) Submitted: 8/31/2009 3:31:07 AM : Outperform Start Price: $13.16 SMTS Score: +0.32

unique product

Recs

0
Member Avatar comansense (64.20) Submitted: 8/6/2009 12:32:38 PM : Outperform Start Price: $13.31 SMTS Score: -3.26

discount price, low risk, sizable upside.

Recs

0
Member Avatar 220330 (70.00) Submitted: 7/25/2009 3:04:42 PM : Outperform Start Price: $14.00 SMTS Score: -11.04

lots of cash, no debt

Recs

0
Member Avatar 00100 (96.79) Submitted: 6/16/2009 2:34:37 PM : Outperform Start Price: $16.67 SMTS Score: -35.03

SMTS

Recs

0
Member Avatar Wsteh (< 20) Submitted: 4/9/2009 12:16:26 AM : Outperform Start Price: $13.96 SMTS Score: -29.05

Strong moat. Net cash 40% of market cap. Expanding market application.

Recs

0
Member Avatar fatdiesel (95.68) Submitted: 1/30/2009 7:35:54 PM : Outperform Start Price: $14.56 SMTS Score: -39.27

I'm creating Alpha for Motley Fool Pro.

Recs

0
Member Avatar Alex1963 (97.72) Submitted: 1/3/2009 9:24:40 AM : Outperform Start Price: $16.97 SMTS Score: -36.79

Buy if it hits $12. Nice P/B at 2 but I like a lower P/E in this market. No debt, god margins & mgt but no dividend. I think medical is going to be slow until the coming shakeup in insurance begins to take shape. I'd want a bargain price and I missed it in 4/08. I like anything selling at 1/3 of it's 52 week high.

Recs

0
Member Avatar rfaramir (93.35) Submitted: 12/28/2008 11:23:49 PM : Outperform Start Price: $16.28 SMTS Score: -40.59

I like what I read at fool.com about this company. First real temptation I've had to subscribe to HG Paydirt (I already get HG).

Recs

0
Member Avatar snaphooks (< 20) Submitted: 8/18/2008 7:33:20 PM : Outperform Start Price: $24.89 SMTS Score: -31.68

Guru momentum

Recs

0
Member Avatar HisPix (< 20) Submitted: 7/2/2008 4:56:09 PM : Outperform Start Price: $22.89 SMTS Score: -26.91

Will pitch this one a little later.

Recs

1
Member Avatar nacjr (< 20) Submitted: 6/24/2008 8:32:06 AM : Outperform Start Price: $17.35 SMTS Score: -1.10

Given that the company has, still, some available cash left to continue (re) purchasing some of its stock, if they continue on this trail, I believe that the market will reward them.

Recs

0
Member Avatar ninjin274 (58.33) Submitted: 5/12/2008 3:59:37 AM : Outperform Start Price: $16.73 SMTS Score: +3.28

Will touch $28 in few months

Recs

0
Member Avatar tomk0508 (90.37) Submitted: 5/11/2008 6:51:32 PM : Outperform Start Price: $16.73 SMTS Score: +3.28

Great business model solid margins nothing but growth ahead.

Recs

3
Member Avatar vanonuma (56.01) Submitted: 4/23/2008 4:17:50 AM : Outperform Start Price: $15.70 SMTS Score: +7.96

This is the Netflix of Oxygen monitoring. Not too sophisticated, one really convenient product, easy to sell and easy for hospitals to buy. Patients don't get jabbed-- Heck, maybe I will just get started monitoring myself now...

Recs

0
Member Avatar mill2bill (70.88) Submitted: 3/5/2008 10:53:12 PM : Outperform Start Price: $27.29 SMTS Score: -33.83

great company. Stock gets ahead of itself every once in a while, but eanrings growth has been consistent.

Recs

0
Member Avatar toxfinan (< 20) Submitted: 12/12/2007 12:58:57 PM : Outperform Start Price: $21.91 SMTS Score: -12.13

This company should be bought by Johnson andJohnson

Recs

0
Member Avatar wig2007 (< 20) Submitted: 12/1/2007 7:55:57 PM : Outperform Start Price: $19.05 SMTS Score: -3.99

Good consistent growth with PEG < 1. And what's not to like about non-invasive monitoring systems.

Recs

0
Member Avatar SuspectCRo (< 20) Submitted: 6/28/2007 10:52:02 AM : Outperform Start Price: $18.57 SMTS Score: -0.15

strong margins and growth, good liquidity and a niche market in healthcare, should be stong for two years until the next best thing comes out.

Recs

0
Member Avatar themtbinvestor (34.16) Submitted: 3/30/2007 11:45:06 AM : Outperform Start Price: $19.87 SMTS Score: -10.50

pumping all pedals, but no Mad Money word

Results 1 - 20 of 31 1 2 Next »

Featured Broker Partners